Tag:
Medtronic
Latest Headlines
Latest Headlines
Study results rekindle feud between St. Jude and Medtronic
Medtronic dismissed claims that St. Jude's EnligHTN is more effective than its competing product, Symplicity.
Medtronic: DOJ closes inquiry into Infuse sales practices
Medtronic can cross off its list one more lingering legal problem relating to the company's controversial Infuse bone graft material.
Medtronic's Resolute Integrity stent gains CE mark for 7 new indications
Plenty of companies make drug-eluting stents now. And with that competitive environment in mind, Medtronic has taken an interesting track for one of its products in the space: Getting it approved for as many indications as possible.
Medtronic: CRT-Ds are a bargain
The Minnesota medical device giant released results of an economic analysis of the RAFT trial that showed the implant is a cost-effective way to treat patients with mildly symptomatic heart failure.
St. Jude Medical: Long-term ICD survival rates higher than with drugs alone
The Minnesota device company released a substantial follow-up study May 10 at the Heart Rhythm Society conference in Boston to prove its point, which it says showed that ICDs helped boost survival rates for patients with moderate heart failure for at least 11 years after their implants.
Biotronik wins FDA approval for next-gen ICD and CRT-D
The competition to gain market share with next-generation ICD and CRT-Ds just got tougher. German device giant Biotronik won FDA regulatory approval for its new Lumax 740 implantable cardioverter defibrillators and cardiac resynchronization therapy devices.
Neglected AED devices failing at point of use
Hundreds of automated external defibrillators in Canada have failed right when someone was trying to use the devices. And the malfunctions lead to at least 9 deaths, CBC News is reporting.
Minnesota argues for repealing the device tax
So here's a question for the season: Should the U.S. revoke the 2.3% device tax before it rolls into effect next year as part of the national health reform law? It shouldn't be surprising that the medical device industry, for the most part, offers a resounding "Yes." But the arguments are now getting more hard-core as to why.
Medtronic bets IT enhancements will boost revenue
Medtronic has turned to an unlikely source to help boost its annual revenue--IT.
Top 10 Medical Device R&D Budgets
In the face of a sluggish economy barely recovering from its historic collapse in 2008, almost all of the companies made a concerted effort to boost their R&D spending during their 2011 fiscal years.
